Bionik Laboratories

Bionik Laboratories Net Margin

The Net Profit Margin of Bionik Laboratories (BNKL) as of Nov 2, 2026 is -273.99 %. In the previous year, Net Profit Margin was -817.14 % — a change of -66.47% (higher).

Net Margin

-273.99 %

YoY

-66.47%

Last updated:

Net Profit Margin of Bionik Laboratories is 2023 -273.99 % . Net Profit Margin of Bionik Laboratories was 2022 -817.14 % . It decreases by -66.47% higher compared to the previous year.

Bionik Laboratories's net margin stands at -274.0%, up from -325.2% several years earlier.

The Bionik Laboratories Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2015
-492.13 USD
Jan 1, 2017
-688.28 USD
Jan 1, 2018
-1,491.63 USD
Jan 1, 2019
-325.20 USD
Jan 1, 2020
-1,157.95 USD
Jan 1, 2021
-1,141.29 USD
Jan 1, 2022
-817.14 USD
Jan 1, 2023
-273.99 USD
The Bionik Laboratories Net Margin history
YEARNet MarginYoY
-273.99 %-66.47%
-817.14 %-28.40%
-1,141.29 %-1.44%
-1,157.95 %+256.07%
-325.20 %-78.20%
-1,491.63 %+116.72%
-688.28 %+39.86%
-492.13 %+95.22%
-252.10 %+20,041.91%
-1.25 %+87.97%
-0.67 %—
0.00-100.00%
-1.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bionik Laboratories Stock analysis

What does Bionik Laboratories do? Bionik Laboratories Corp. generates revenue through its portfolio of rehabilitation products designed for neurological and mobility-impaired patients. The company offers InMotion ARM, InMotion ARM/HAND, and InMotion Robots as fully developed clinical solutions, with InMotion CONNECT serving as a complementary platform. InMotion Home is in development as an at-home upper extremity therapy product. These products target healthcare providers and rehabilitation centers seeking advanced robotic therapies for stroke and mobility disorders. The company's focus on AI-driven rehabilitation solutions positions it to serve the growing market for smart, patient-centric mobility recovery systems. The business model relies on selling robotic therapy systems and software platforms to clinical facilities and home care settings. InMotion ARM and InMotion ARM/HAND are deployed in professional rehabilitation environments, while InMotion Home aims to expand access to therapy beyond clinical walls. InMotion CONNECT supports data-driven treatment planning and progress tracking, enhancing the value proposition for healthcare institutions. The company monetizes through product sales and potentially service contracts for its AI-enhanced rehabilitation systems. Bionik Laboratories Corp. targets healthcare providers specializing in neurological rehabilitation, including hospitals and outpatient clinics. Its products address upper and lower extremity rehabilitation needs, with a primary focus on stroke recovery. The company's development pipeline includes three market-ready products and three in various stages of development, ensuring a steady stream of revenue opportunities as products progress from development to commercialization. Bionik Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bionik Laboratories stock

Net Profit Margin of Bionik Laboratories is -273.99 % in 2023.

Net Profit Margin of Bionik Laboratories changed from -817.14 % to -273.99 %, representing a -66.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Bionik Laboratories since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Bionik Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bionik Laboratories

All Key Metrics — Bionik Laboratories